These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38872972)

  • 1. Oral phytate supplementation on the progression of mild cognitive impairment, brain iron deposition and diabetic retinopathy in patients with type 2 diabetes: a concept paper for a randomized double blind placebo controlled trial (the PHYND trial).
    Pujol A; Sanchis P; Tamayo MI; Nicolau J; Grases F; Espino A; Estremera A; Rigo E; Amengual GJ; Rodríguez M; Ribes JL; Gomila I; Simó-Servat O; Masmiquel L
    Front Endocrinol (Lausanne); 2024; 15():1332237. PubMed ID: 38872972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial.
    Scott IU; Jackson GR; Quillen DA; Klein R; Liao J; Gardner TW
    JAMA Ophthalmol; 2014 Sep; 132(9):1137-42. PubMed ID: 24969516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Acupuncture on Brain Iron Deposition and Body Iron Metabolism in Vascular Cognitive Impairment: Protocol for a Randomized Controlled Trial.
    Wu M; Chen L; Wang Y; Li Y; An Y; Wu R; Zhang Y; Gao J; Su K; Feng X
    JMIR Res Protoc; 2024 Jun; 13():e56484. PubMed ID: 38885500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial.
    Baye E; Menon K; de Courten MP; Earnest A; Cameron J; de Courten B
    BMJ Open; 2017 Sep; 7(9):e017691. PubMed ID: 28864708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dietary prebiotic supplementation on advanced glycation, insulin resistance and inflammatory biomarkers in adults with pre-diabetes: a study protocol for a double-blind placebo-controlled randomised crossover clinical trial.
    Kellow NJ; Coughlan MT; Savige GS; Reid CM
    BMC Endocr Disord; 2014 Jul; 14():55. PubMed ID: 25011647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain iron deposition in type 2 diabetes mellitus with and without mild cognitive impairment-an in vivo susceptibility mapping study.
    Yang Q; Zhou L; Liu C; Liu D; Zhang Y; Li C; Shang Y; Wei X; Li C; Wang J
    Brain Imaging Behav; 2018 Oct; 12(5):1479-1487. PubMed ID: 29297155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the effect of curcumin and zinc co-supplementation on glycemic measurements, lipid profiles, and inflammatory and antioxidant biomarkers in overweight or obese prediabetic patients: a study protocol for a randomized double-blind placebo-controlled phase 2 clinical trial.
    Karandish M; Mozaffari-Khosravi H; Mohammadi SM; Azhdari M; Cheraghian B
    Trials; 2020 Nov; 21(1):991. PubMed ID: 33256795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment.
    McCleery J; Abraham RP; Denton DA; Rutjes AW; Chong LY; Al-Assaf AS; Griffith DJ; Rafeeq S; Yaman H; Malik MA; Di Nisio M; Martínez G; Vernooij RW; Tabet N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011905. PubMed ID: 30383288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feasibility of 3-month melatonin supplementation for brain oxidative stress and sleep in mild cognitive impairment: protocol for a randomised, placebo-controlled study.
    Menczel Schrire Z; Phillips CL; Duffy SL; Marshall NS; Mowszowski L; La Monica HM; Gordon CJ; Chapman JL; Saini B; Lewis SJG; Naismith SL; Grunstein RR; Hoyos CM
    BMJ Open; 2021 Feb; 11(2):e041500. PubMed ID: 33568368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and design of the CAROLINA® - cognition substudy: a randomised controlled trial on cognitive outcomes of linagliptin versus glimepiride in patients with type 2 diabetes mellitus.
    Biessels GJ; Janssen J; van den Berg E; Zinman B; Espeland MA; Mattheus M; Johansen OE;
    BMC Neurol; 2018 Jan; 18(1):7. PubMed ID: 29334906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Memory advancement by intranasal insulin in type 2 diabetes (MemAID) randomized controlled clinical trial: Design, methods and rationale.
    Galindo-Mendez B; Trevino JA; McGlinchey R; Fortier C; Lioutas V; Novak P; Mantzoros CS; Ngo L; Novak V
    Contemp Clin Trials; 2020 Feb; 89():105934. PubMed ID: 31923471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial.
    Sjølie AK; Klein R; Porta M; Orchard T; Fuller J; Parving HH; Bilous R; Chaturvedi N;
    Lancet; 2008 Oct; 372(9647):1385-93. PubMed ID: 18823658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A proof of concept phase II study with the PDE-4 inhibitor roflumilast in patients with mild cognitive impairment or mild Alzheimer's disease dementia (ROMEMA): study protocol of a double-blind, randomized, placebo-controlled, between-subjects trial.
    Possemis N; Verhey F; Prickaerts J; Blokland A; Ramakers I
    Trials; 2024 Mar; 25(1):162. PubMed ID: 38438923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol.
    Barbera M; Lehtisalo J; Perera D; Aspö M; Cross M; De Jager Loots CA; Falaschetti E; Friel N; Luchsinger JA; Gavelin HM; Peltonen M; Price G; Neely AS; Thunborg C; Tuomilehto J; Mangialasche F; Middleton L; Ngandu T; Solomon A; Kivipelto M;
    Alzheimers Res Ther; 2024 Jan; 16(1):23. PubMed ID: 38297399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of synbiotic supplementation on gut microbiome, serum level of TNF-α, and expression of microRNA-126 and microRNA-146a in patients with type 2 diabetes mellitus: study protocol for a double-blind controlled randomized clinical trial.
    Zeinali F; Aghaei Zarch SM; Vahidi Mehrjardi MY; Kalantar SM; Jahan-Mihan A; Karimi-Nazari E; Fallahzadeh H; Hosseinzadeh-Shamsi-Anar M; Rahmanian M; Fazeli MR; Mozaffari-Khosravi H
    Trials; 2020 Apr; 21(1):324. PubMed ID: 32290852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial.
    Barchetta I; Del Ben M; Angelico F; Di Martino M; Fraioli A; La Torre G; Saulle R; Perri L; Morini S; Tiberti C; Bertoccini L; Cimini FA; Panimolle F; Catalano C; Baroni MG; Cavallo MG
    BMC Med; 2016 Jun; 14():92. PubMed ID: 27353492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life.
    Rutjes AW; Denton DA; Di Nisio M; Chong LY; Abraham RP; Al-Assaf AS; Anderson JL; Malik MA; Vernooij RW; Martínez G; Tabet N; McCleery J
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011906. PubMed ID: 30556597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.